Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Then in an announcement on Tuesday, the drugmaker unveiled that the National Medical Products Administration (NMPA), Chinas top drug regulator, had allowed the injection to be used in weight reduction, making it the first GLP-1 receptor agonist officially available in the country for people who wish to lose weight but for diabetes-unrelated reasons
Both gave me renewed vitality
Its really important with these types of drugs that pharmacists and providers make sure to provide their patients with adequate counseling, education, and materials and be available when patients have questions, says Tenille Davis, a pharmacist and chief advocacy officer of the Alliance for Pharmacy Compounding, which represents the interests of compounding pharmacies in the U.S
Jens Juul Holst (University of Copenhagen) Q&A: A conversation with GLP-1 co-discoverer Jens Juul Holst on the future of incretin-based drugs Medicines based on glucagon-like peptide-1 (GLP-1) have revolutionized the treatment of diabetes and obesity
For patients with a BMI of 30 or higher, or a BMI of 27 or higher accompanied by weight-related health conditions such as hypertension or dyslipidemia, Ozempic may be an appropriate consideration
